Showing results (211-220 of 275) with videos related to

Sort By:
Pageof 28
Communications Medicine|June 24, 2026
Capacity building for genomic surveillance of mpox and other emerging diseases in resource-limited settings within the African Great Lakes regionLeonard Schuele, Néhémie Nzoyikorera, Jean Claude Udahemuka, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 14, 2020
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic AcidJan Freark de Boer, Hilde D de Vries, Anna Palmiotti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 28, 2024
Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence studyElise De Vos, Liesbeth Van Gestel, Isabel Brosius, et al.
The Journal of Clinical Investigation|September 9, 2021
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19Muriel Aguilar-Bretones, Brenda M Westerhuis, Matthijs P Raadsen, et al.
The New England Journal of Medicine|January 19, 2022
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S PrimingRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Science Advances|April 29, 2021
The evolution of mammalian brain sizeJ B Smaers, R S Rothman, D R Hudson, et al.
Frontiers in Immunology|December 16, 2022
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocolNgoc H Tan, Roos S G Sablerolles, Wim J R Rietdijk, et al.
Nature Medicine|October 18, 2022
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individualsLuca M Zaeck, Mart M Lamers, Babs E Verstrepen, et al.
Pageof 28